Logo image of AAT.CA

ATI AIRTEST TECHNOLOGIES INC (AAT.CA) Stock Fundamental Analysis

TSX-V:AAT - TSX Venture Exchange - CA00208E3077 - Common Stock - Currency: CAD

0.015  0 (0%)

Fundamental Rating

0

AAT gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of AAT have multiple concerns. AAT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AAT has reported negative net income.
AAT had a negative operating cash flow in the past year.
AAT had negative earnings in each of the past 5 years.
In the past 5 years AAT always reported negative operating cash flow.
AAT.CA Yearly Net Income VS EBIT VS OCF VS FCFAAT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

Industry RankSector Rank
ROA -15.01%
ROE N/A
ROIC N/A
ROA(3y)-203.4%
ROA(5y)-183.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AAT.CA Yearly ROA, ROE, ROICAAT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400

1.3 Margins

AAT's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.57%
GM growth 5Y-0.06%
AAT.CA Yearly Profit, Operating, Gross MarginsAAT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

AAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AAT has been increased compared to 1 year ago.
Compared to 1 year ago, AAT has an improved debt to assets ratio.
AAT.CA Yearly Shares OutstandingAAT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
AAT.CA Yearly Total Debt VS Total AssetsAAT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M 2M

2.2 Solvency

AAT has an Altman-Z score of -23.12. This is a bad value and indicates that AAT is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -23.12
ROIC/WACCN/A
WACC5.61%
AAT.CA Yearly LT Debt VS Equity VS FCFAAT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -2M -4M -6M

2.3 Liquidity

A Current Ratio of 0.26 indicates that AAT may have some problems paying its short term obligations.
AAT has a Quick Ratio of 0.26. This is a bad value and indicates that AAT is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.05
AAT.CA Yearly Current Assets VS Current LiabilitesAAT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

AAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.73%.
Looking at the last year, AAT shows a very negative growth in Revenue. The Revenue has decreased by -10.13% in the last year.
The Revenue has been decreasing by -7.72% on average over the past years.
EPS 1Y (TTM)-21.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.91%
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y-11.77%
Revenue growth 5Y-7.72%
Sales Q2Q%-29.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AAT.CA Yearly Revenue VS EstimatesAAT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAT.CA Price Earnings VS Forward Price EarningsAAT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAT.CA Per share dataAAT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATI AIRTEST TECHNOLOGIES INC

TSX-V:AAT (7/11/2024, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-28 2024-05-28
Earnings (Next)08-27 2024-08-27
Inst Owners1.73%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap967.68K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.03
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.01%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.44%
FCFM N/A
ROA(3y)-203.4%
ROA(5y)-183.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.57%
GM growth 5Y-0.06%
F-Score4
Asset Turnover1.61
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.05
Altman-Z -23.12
F-Score4
WACC5.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y-11.77%
Revenue growth 5Y-7.72%
Sales Q2Q%-29.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.03%
OCF growth 3YN/A
OCF growth 5YN/A